Epostim (epoetin alfa)
Biosimilar
- Region
- 🇪🇺 EU
- Active substance
- epoetin alfa
- Company
- Reliance GeneMedix Plc
- Status
- Application withdrawn
- Therapeutic area
- Anemia
- Designations
- Biosimilar
- Application
- EMEA/H/C/002265
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Aranesp Authorised · Amgen Europe B.V.
- 🇪🇺 Epoetin Alfa Hexal Authorised · Hexal AG
- 🇪🇺 Binocrit Authorised · Sandoz GmbH
- 🇪🇺 Abseamed Authorised · Medice Arzneimittel Pütter GmbH Co. KG
- 🇪🇺 Nespo Withdrawn · Dompé Biotec S.p.A.
Follow Epostim
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.